ECSP078038A - Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales - Google Patents

Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales

Info

Publication number
ECSP078038A
ECSP078038A EC2007008038A ECSP078038A ECSP078038A EC SP078038 A ECSP078038 A EC SP078038A EC 2007008038 A EC2007008038 A EC 2007008038A EC SP078038 A ECSP078038 A EC SP078038A EC SP078038 A ECSP078038 A EC SP078038A
Authority
EC
Ecuador
Prior art keywords
micronized
chlorophenyl
salts
pharmaceutical formulations
immediate release
Prior art date
Application number
EC2007008038A
Other languages
English (en)
Inventor
Adrian Funke
Torsten Wagner
Thomas Backensfeld
Kai Juergens
Kai Thode
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ECSP078038A publication Critical patent/ECSP078038A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a formulaciones farmacéuticas sólidas de liberación inmediata y con una carga elevada de droga que comprenden (4-clorofenil)[4-(4-piridilmetil)-ftalazin-1-ilo] no micronizado, y sales del mismo aceptables para uso farmacéutico.
EC2007008038A 2005-06-07 2007-12-19 Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales ECSP078038A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090166A EP1731153A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl| and salts thereof

Publications (1)

Publication Number Publication Date
ECSP078038A true ECSP078038A (es) 2008-01-23

Family

ID=34938467

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007008038A ECSP078038A (es) 2005-06-07 2007-12-19 Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales

Country Status (21)

Country Link
EP (2) EP1731153A1 (es)
JP (1) JP2008542420A (es)
KR (1) KR20080031005A (es)
CN (1) CN101242840A (es)
AR (1) AR053889A1 (es)
AU (1) AU2006256852A1 (es)
BR (1) BRPI0613393A2 (es)
CA (1) CA2610975A1 (es)
CR (1) CR9563A (es)
DO (1) DOP2006000127A (es)
EC (1) ECSP078038A (es)
GT (1) GT200600242A (es)
IL (1) IL187905A0 (es)
MX (1) MX2007015494A (es)
NO (1) NO20080065L (es)
PE (1) PE20070319A1 (es)
RU (1) RU2007147951A (es)
TW (1) TW200716115A (es)
UY (1) UY29582A1 (es)
WO (1) WO2006131393A1 (es)
ZA (1) ZA200800112B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

Also Published As

Publication number Publication date
DOP2006000127A (es) 2006-12-15
IL187905A0 (en) 2008-03-20
EP1888072A1 (en) 2008-02-20
RU2007147951A (ru) 2009-07-20
NO20080065L (no) 2008-03-06
AR053889A1 (es) 2007-05-23
CN101242840A (zh) 2008-08-13
AU2006256852A1 (en) 2006-12-14
UY29582A1 (es) 2007-01-31
AU2006256852A8 (en) 2006-12-14
KR20080031005A (ko) 2008-04-07
WO2006131393A1 (en) 2006-12-14
TW200716115A (en) 2007-05-01
GT200600242A (es) 2007-02-09
MX2007015494A (es) 2008-02-22
PE20070319A1 (es) 2007-04-12
JP2008542420A (ja) 2008-11-27
EP1731153A1 (en) 2006-12-13
BRPI0613393A2 (pt) 2011-01-11
CR9563A (es) 2008-02-20
CA2610975A1 (en) 2006-12-14
ZA200800112B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
AR124134A2 (es) Formulación de uso tópico para un inhibidor de jak
MX2009010289A (es) Composiciones para administracion nasal.
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
FR2949062B1 (fr) Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
ECSP077243A (es) Formulación de pelet de liberación extendida que contiene pramipexol o una de sus sales farmacéuticamente aceptable, un método para su fabricación y su uso
UY31647A1 (es) Forma de dosificación farmacéutica para la administración oral de inhibidor de tirosina quinasa
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
DOP2010000299A (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
CL2019003619A1 (es) Preparación sólida para administración oral.
CO6612204A2 (es) Nuevas composiciones de 1-(2(2.4 dimetil-fenilsulfanil)- fenil) piperazina
CO6321158A2 (es) Formulacion oral
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CO6311067A2 (es) Preparación de comprimido con liberación retardada que contiene polivinilpirrolidonas y principio activo
MX2020004107A (es) Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas.
ECSP078037A (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] micronizado, y sus sales
ECSP078038A (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales
ATE479427T1 (de) Pharmazeutische zusammensetzung mit candesartan- cilexetil
TR201803451T4 (tr) Olmesartan formülasyonlari.
PY09012363A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad
CU20070271A7 (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-4-piridilmetil) ftalazin-1-ilo] no micronizado y sus sales
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
CR11306A (es) Nuevos compuestos farmaceuticos
WO2007093168A3 (de) Schnell freisetzende irbesartan-haltige pharmazeutische zusammensetzung